294 related articles for article (PubMed ID: 27373111)
1. NEOVASCULAR SECONDARY GLAUCOMA, ETIOLOGY AND PATHOGENESIS.
Barac IR; Pop MD; Gheorghe AI; Taban C
Rom J Ophthalmol; 2015; 59(1):24-8. PubMed ID: 27373111
[TBL] [Abstract][Full Text] [Related]
2. [Neovascular glaucoma--etipathogeny and diagnosis].
Călugăru D; Călugăru M
Oftalmologia; 2012; 56(2):3-14. PubMed ID: 23424756
[TBL] [Abstract][Full Text] [Related]
3. A review of neovascular glaucoma. Etiopathogenesis and treatment.
Dumbrăveanu L; Cușnir V; Bobescu D
Rom J Ophthalmol; 2021; 65(4):315-329. PubMed ID: 35087972
[TBL] [Abstract][Full Text] [Related]
4. [Intravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 cases].
Douat J; Auriol S; Mahieu-Durringer L; Ancèle E; Pagot-Mathis V; Mathis A
J Fr Ophtalmol; 2009 Nov; 32(9):652-63. PubMed ID: 19892433
[TBL] [Abstract][Full Text] [Related]
5. Iris neovascularization and neovascular glaucoma in neurofibromatosis type 1: report of 3 cases in children.
Al Freihi SH; Edward DP; Nowilaty SR; Abouammoh MA; Morales J
J Glaucoma; 2013; 22(4):336-41. PubMed ID: 22138687
[TBL] [Abstract][Full Text] [Related]
6. [Neovascular glaucoma: aetiology, pathogenesis and treatment].
Löffler KU
Ophthalmologe; 2006 Dec; 103(12):1057-63; quiz 1064. PubMed ID: 17058065
[TBL] [Abstract][Full Text] [Related]
7. Neovascular glaucoma - A review.
Senthil S; Dada T; Das T; Kaushik S; Puthuran GV; Philip R; Rani PK; Rao H; Singla S; Vijaya L
Indian J Ophthalmol; 2021 Mar; 69(3):525-534. PubMed ID: 33595466
[TBL] [Abstract][Full Text] [Related]
8. Neovascular glaucoma.
Konareva-Kostianeva M
Folia Med (Plovdiv); 2005; 47(2):5-11. PubMed ID: 16544843
[TBL] [Abstract][Full Text] [Related]
9. Neovascular Glaucoma: An Update.
Kalogeropoulos D; Moussa G; Sung VC; Pappa C; Kalogeropoulos C
Klin Monbl Augenheilkd; 2023 Mar; 240(3):305-315. PubMed ID: 36436509
[TBL] [Abstract][Full Text] [Related]
10. A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol for a randomised controlled trial.
Lorenz K; Scheller Y; Bell K; Grus F; Ponto KA; Bock F; Cursiefen C; Flach J; Gehring M; Peto T; Silva R; Tal Y; Pfeiffer N
Trials; 2017 Mar; 18(1):128. PubMed ID: 28302155
[TBL] [Abstract][Full Text] [Related]
11. Bevacizumab as adjuvant for neovascular glaucoma.
Beutel J; Peters S; Lüke M; Aisenbrey S; Szurman P; Spitzer MS; Yoeruek E; ; Grisanti S
Acta Ophthalmol; 2010 Feb; 88(1):103-9. PubMed ID: 18811641
[TBL] [Abstract][Full Text] [Related]
12. Neovascular Glaucoma.
Havens SJ; Gulati V
Dev Ophthalmol; 2016; 55():196-204. PubMed ID: 26501989
[TBL] [Abstract][Full Text] [Related]
13. Aqueous Inflammation and Ischemia-Related Biomarkers in Neovascular Glaucoma with Stable Iris Neovascularization.
Sun C; Zhang H; Tang Y; Chen Y; Li Y; Nie C; Gu J; Luo L; Wang Z
Curr Eye Res; 2020 Dec; 45(12):1504-1513. PubMed ID: 32339463
[No Abstract] [Full Text] [Related]
14. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma.
Batioğlu F; Astam N; Ozmert E
Int Ophthalmol; 2008 Feb; 28(1):59-61. PubMed ID: 17609852
[TBL] [Abstract][Full Text] [Related]
15. [Effect of Intravitreal Bevacizumab Injection on Iris and Iridocorneal Angle Neovascularization in Neovascular Glaucoma].
Ishibashi S; Kondo H
J UOEH; 2015 Dec; 37(4):299-304. PubMed ID: 26667197
[TBL] [Abstract][Full Text] [Related]
16. Panretinal cryopexy for the management of neovascularization of the iris.
Stefaniotou M; Paschides CA; Psilas K
Ophthalmologica; 1995; 209(3):141-4. PubMed ID: 7543193
[TBL] [Abstract][Full Text] [Related]
17. Neovascular glaucoma: etiology, diagnosis and prognosis.
Shazly TA; Latina MA
Semin Ophthalmol; 2009; 24(2):113-21. PubMed ID: 19373696
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
[TBL] [Abstract][Full Text] [Related]
19. Angiographic changes in iris and iridocorneal angle neovascularization after intravitreal bevacizumab injection.
Ishibashi S; Tawara A; Sohma R; Kubota T; Toh N
Arch Ophthalmol; 2010 Dec; 128(12):1539-45. PubMed ID: 21149776
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone implants and neovascular glaucoma in central retinal vein occlusion.
Joshi L; Tomkins-Netzer O; Menezo V; Sallam A; Kirkpatrick N; Lightman S; Taylor SR
Acta Ophthalmol; 2013 May; 91(3):e239-40. PubMed ID: 23241218
[No Abstract] [Full Text] [Related]
[Next] [New Search]
